Ramucirumab (LY3009806)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ramucirumab (LY3009806), covering 2019-03-08 to 2023-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer [Phase 1]